What is NDC 25021-195?

25021-195 is the product NDC for Caspofungin Acetate, Caspofungin acetate 7 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by Sagent Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.

Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Caspofungin Acetate?

11 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Caspofungin Acetate NDC 25021-195 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-195Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0195Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-195-10	2502101951025021019510	1 VIAL in 1 CARTON (25021-195-10) / 10 mL in 1 VIALMarketed from Jul 15, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Caspofungin Acetate
Generic name (nonproprietary): caspofungin acetate
Active ingredients: Caspofungin acetate — 7 mg/mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Sagent PharmaceuticalsNDC labeler code 25021
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207092
Marketing start: Jul 15, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Lipopeptides (Chemical structure)
Identifiers: Product ID 25021-195_97e9117d-ea0b-414e-b5ac-26a8acf73400SPL ID 97e9117d-ea0b-414e-b5ac-26a8acf73400SPL set ID 08fb61ee-a05a-4ce1-934c-8cd26c5733dbRxCUI 828539, 828755UNII VUW370O5QE
Pharmacologic class: Echinocandin Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021019510 followed by a unit qualifier and the quantity

Package 25021-0195-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 29, 2026.

Indications (excerpt from the label)

Caspofungin acetate for injection is an echinocandin antifungal indicated in adults and pediatric patients (3 months of age and older) for: Empirical therapy for presumed fungal infections in febrile, neutropenic patients. ( 1 ) Treatment of candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. ( 1 ) Treatment of esophageal candidiasis. ( 1 ) Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies. ( 1 ) 1.1 Empirical Therapy for Presumed Fungal Infections in Febrile, Neutropenic Patients Caspofungin acetate for injection is indicated as empirical therapy for presumed fungal infecti…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 25021-195

What is NDC 25021-195?: 25021-195 is the product NDC for Caspofungin Acetate, Caspofungin acetate 7 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by Sagent Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Caspofungin Acetate.
What is the active ingredient?: Caspofungin acetate.
Who is the labeler?: Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Caspofungin Acetate?: 11 other product NDCs are listed under this name. See all Caspofungin Acetate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Caspofungin Acetate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Caspofungin Acetate	Caspofungin acetate 7 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	65897-0004	65897-0004-01
Caspofungin Acetate	Caspofungin acetate 5 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	65897-0002	65897-0002-01
Caspofungin Acetate	Caspofungin acetate 5 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Sagent Pharmaceuticals	25021-194	25021-0194-10
Caspofungin Acetate	Caspofungin acetate 5 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fosun Pharma USA Inc.	72266-106	72266-0106-01
Caspofungin Acetate	Caspofungin acetate 7 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fosun Pharma USA Inc.	72266-107	72266-0107-01
Caspofungin Acetate	Caspofungin acetate 5 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Sandoz Inc	0781-3421	00781-3421-94
Caspofungin Acetate	Caspofungin acetate 7 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Sandoz Inc	0781-3423	00781-3423-94
Caspofungin Acetate	Caspofungin acetate 5 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Gland Pharma Limited	68083-158	68083-0158-01
Caspofungin Acetate	Caspofungin acetate 7 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Gland Pharma Limited	68083-159	68083-0159-01
Caspofungin Acetate	Caspofungin acetate 5 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-356	63323-0356-10

All 12 Caspofungin Acetate NDCs

Other NDCs under ANDA 207092

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207092
Product	Strength	Form · route	Labeler	Product NDC
Caspofungin Acetate	Caspofungin acetate 5 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Sagent Pharmaceuticals	25021-194
Caspofungin Acetate	Caspofungin acetate 5 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Gland Pharma Limited	68083-158
Caspofungin Acetate	Caspofungin acetate 7 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Gland Pharma Limited	68083-159
Caspofungin Acetate	Caspofungin acetate 5 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fosun Pharma USA Inc.	72266-106
Caspofungin Acetate	Caspofungin acetate 7 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fosun Pharma USA Inc.	72266-107